Loading stock data…
Elevance Health, Inc. (ELV)
$377.68-1.63 (-0.43%)
Market ClosedLast close Jul 24
Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Elevance Health, Inc. in the Healthcare sector is trading at $377.68 with a market capitalization of $85.0B. Wall Street consensus targets $449.10 (21 analysts), implying a +18.9% move over the next 12 months. The stock is currently 13% below its 52-week high of $436.24, remaining 8.5% above its 200-day moving average. On fundamentals, Piotroski 4/9 shows mixed financial quality. The Whystock Score of 100/100 reflects bullish alignment across trend, valuation and analyst targets.
Ecosystem Influences
Sell-side targets imply +18.9% upside over 12 months
Long-term trend bullish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Quarterly Financials
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $50.18B↑ | $49.75B↓ | $50.71B↑ | $49.78B↑ | $48.89B |
| Gross Profit | — | — | — | — | — |
| Operating Income | $2.66B↑ | $581.00M↓ | $1.76B↓ | $2.63B↓ | $3.14B |
| Net Income | $1.76B↑ | $547.00M↓ | $1.19B↓ | $1.74B↓ | $2.18B |
Peer Comparison
JNJUNHPFE
Fundamentals
Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. The company operates in four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of heal...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$84.97B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
16.57
Beta
Defensive asset. Lower volatility than the S&P 500.
0.67
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
1.81%
ROE
Average efficiency. Growth may require heavy reinvestment.
11.94%
Volume
Today's trading volume
734,833
Recent News
Billionaire Investor Seth Klarman’s Top 5 Stocks: Would He Buy More Today?
Seth Klarman's Baupost Group just revealed its five largest stock positions, and the list includes a little-known industrial distributor posting explosive earnings growth alongside household names bleeding on the front page. Reverse-engineering his logic reveals a portfolio built for a very specific payoff.
The Real Price of UnitedHealth Stock Is Two Years Away
The healthcare giant looks expensive on today's numbers, but a patient investor is effectively buying it at a significant discount to that price.
Can Humana Beat Q2 Earnings Estimates on Growing Premiums?
HUM enters Q2 earnings with strong premium and membership growth expectations, but rising medical costs and expenses could test its bottom line.
Edwards' Q2 Earnings & Revenues Top Estimates, Stock Rises
EW beats Q2 earnings and revenue estimates as strong TAVR demand, and mitral and tricuspid therapy adoption lift results and guidance.
TMO Q2 Earnings & Revenues Top Estimates, Stock Up in Pre-Market
Thermo Fisher beats Q2 earnings and revenue estimates as organic growth and stronger customer activity lift results, sending shares higher in pre-market trading.